Vanrafia (Atrasentan)

Atrasentan is a medicine for adults with IgA nephropathy, a kidney disease. It works by blocking a natural chemical that tightens blood vessels and damages the kidney's filters, which lowers protein in the urine. It is taken as a pill once a day.

Brand names:Vanrafia
Medication

What people taking Vanrafia (Atrasentan) report

Every report comes from a Lived member, sent anonymously.

Have you tried Vanrafia (Atrasentan) for IgA Nephropathy?

NameHow it went

About Vanrafia (Atrasentan)

What It's For

Atrasentan, sold as Vanrafia, is a prescription tablet for adults with primary IgA nephropathy, a kidney disease in which clumps of an antibody called immunoglobulin A (IgA) lodge in the kidney's filters and inflame them. The damaged filters leak protein into the urine, and over years the scarring can lead to chronic kidney disease or kidney failure. Atrasentan is meant for people whose disease is at risk of progressing quickly, which generally means a urine protein-to-creatinine ratio (UPCR) of 1.5 g/g or higher. UPCR is a urine test that estimates how much protein the kidneys are losing; a healthy result is far below that level. The US Food and Drug Administration (FDA) granted accelerated approval because atrasentan clearly lowers urine protein, a sign linked to slower kidney damage in this disease. It has not yet been established that it slows the loss of kidney function itself, and continued approval depends on confirming that benefit. It is usually added to a blood pressure medicine that also protects the kidneys, such as an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker, rather than replacing it.

How It Works

Endothelin-1 is a natural signaling molecule that narrows blood vessels and, in the kidney, encourages inflammation, scarring and protein leakage through the filters. In IgA nephropathy it appears to drive part of the ongoing damage. Atrasentan is an endothelin receptor antagonist: it blocks the type A receptor that endothelin-1 acts on, quieting that signal. With less endothelin activity, pressure and stress on the kidney's filters ease and less protein spills into the urine. It does not remove the IgA deposits or treat the underlying immune problem, which is why it is used alongside other kidney-protective care.

Dosage & Administration

Atrasentan comes as a single strength, 0.75 mg, taken by mouth once a day with or without food. Swallow the tablet whole; do not cut, crush or chew it. If a dose is missed, take the next one at the usual time and do not double up. Before the first prescription, anyone who could become pregnant needs a negative pregnancy test and a reliable form of birth control. A blood test of liver function is also done before starting.

Side Effects

Swelling from fluid retention, usually in the ankles or legs, is the most common side effect, reported in about 1 in 10 people in the main trial compared with about 7 in 100 on placebo. Contact the care team about unusual weight gain or noticeable swelling; a water pill (diuretic) or a pause in treatment may help. Atrasentan also tends to lower hemoglobin slightly, partly because the extra fluid dilutes the blood, so some people show mild anemia on blood tests. Blood pressure often drops a few points, which rarely causes symptoms. Medicines in this family have caused liver injury. With atrasentan, trial participants had only temporary rises in liver enzymes, but the care team checks liver tests as needed. Report yellowing of the skin or eyes, dark urine, pain in the upper right abdomen, unexplained nausea or vomiting, loss of appetite, fever or itching.

Interactions & Warnings

Atrasentan carries the FDA's most serious warning, a boxed warning, because it may cause major birth defects if taken during pregnancy, based on animal studies. It must not be used during pregnancy. Anyone who can become pregnant should use effective birth control before starting, throughout treatment and for two weeks after stopping, and should know how to get emergency contraception if birth control fails. If a period is late or pregnancy is suspected, contact the prescriber right away for a pregnancy test; atrasentan is stopped as soon as possible if pregnancy is confirmed. Breastfeeding is not advised during treatment. Atrasentan may lower sperm counts. In a study of people with diabetic kidney disease, counts returned to normal within about three months of stopping, but this has not been studied in IgA nephropathy, so men planning a family should raise it. Some medicines change atrasentan levels enough to matter. Rifampin, an antibiotic used for tuberculosis, and other medicines that speed up its breakdown can make it much less effective. Cyclosporine, an immune-suppressing drug used after transplants, roughly quadruples atrasentan levels and raises the chance of side effects. Both kinds of combination should be avoided, so share a full medicine and supplement list with the prescriber and pharmacist. Atrasentan is not started in people with severe liver disease and has not been studied in people with IgA nephropathy who also have heart failure.

What to Expect

Atrasentan works on urine protein rather than on how someone feels, so most people notice no change day to day. In the main trial, urine protein fell by about 38% after nine months, compared with about 3% on placebo. Follow-up urine and blood tests show whether it is working and track kidney function, liver tests, hemoglobin and fluid. After about two and a half years, people taking atrasentan lost somewhat less kidney function than those on placebo, but the main comparison narrowly missed the usual threshold for statistical confidence, and the FDA has not yet concluded that it slows kidney decline. It is a long-term treatment, and IgA nephropathy care still rests on blood pressure control, other kidney-protective medicines and regular monitoring.

Questions to Ask Your Doctor

  1. 1.Is my urine protein high enough that atrasentan is likely to help, and what result would tell us it is working?
  2. 2.How does atrasentan fit with my current kidney medicines, and are there other options such as sparsentan or steroid-based treatments?
  3. 3.What birth control plan works with this medicine, and what should I do if I think I might be pregnant?
  4. 4.How often will I need blood and urine tests, and what swelling or weight change should prompt a call?
  5. 5.Do any of my current medicines or supplements interact with atrasentan?

Last reviewed • Oct 2026

Educational content, not medical advice.